Allelic losses at chromosome 3p are seen in human papilloma virus 16 associated transitional cell carcinoma of the cervix

被引:9
作者
Maitra, A
Wistuba, II
Gibbons, D
Gazdar, AF
Albores-Saavedra, J
机构
[1] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75235 USA
[2] Univ Texas, SW Med Ctr, Hamon Ctr therapeut Oncol Res, Dallas, TX 75235 USA
关键词
transitional cell carcinoma; cervix; human papilloma virus; chromosome; 3; 9; P53;
D O I
10.1006/gyno.1999.5489
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Transitional cell carcinomas (TCCs) of the cervix are rare neoplasms of the female genital tract. Although these tumors display urothelial differentiation, there is controversy regarding their histogenetic relationship to squamous cell carcinomas (SCC) of the cervix versus transitional cell carcinomas of the bladder. Methods. We performed partial allelotyping of five TCCs of the cenix using 23 polymorphic markers located on chromosomes 3p and 9, which demonstrate frequent and early losses in cervical SCC and urothelial TCC, respectively. Multiplex polymerase chain reaction was used on DNA extracted from archival paraffin-embedded tissue using precise microdissection. Additionally, P53 gene mutation analysis was performed using single-strand confirmation polymorphism (SSCP) and the presence of human papilloma virus (HPV) sequences was analyzed using general and specific (types 16 and 18) primers. Results. General HPV sequences were demonstrated in all cases, but the oncogenic strain HPV 16 was present in only three (60%) of the five tumors; no HPV 18 was detected in any sample. Three of five TCCs, all harboring HPV 16 sequences, demonstrated concurrent allelic losses at several 3p loci (specifically 3p12, 3p14.2 [the FHIT gene locus], 3p21.3, and 3p22-24.2). LOH at a single locus on 9q32-qter was demonstrated in one tumor; no other deletions were seen on chromosome 9. P53 gene mutations in exons 5-8 were absent by SSCP analysis. Conclusions, The infrequent involvement of chromosome 9 in TCCs of the cervix, along with the concurrent presence of 3p LOH and oncogenic HPV 16 in a subset of tumors, suggests a closer histogenetic relationship of this neoplasm to cervical SCCs rather than urothelial TCCs. (C) 1999 Academic Press.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 68 条
  • [1] TRANSITIONAL-CELL NEOPLASMS (CARCINOMAS AND INVERTED PAPILLOMAS) OF THE UTERINE CERVIX - A REPORT OF 5 CASES
    ALBORESSAAVEDRA, J
    YOUNG, RH
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (10) : 1138 - 1145
  • [2] Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas
    Baay, MFD
    Quint, WGV
    Koudstaal, J
    Hollema, H
    Duk, JM
    Burger, MPM
    Stolz, E
    Herbrink, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) : 745 - 747
  • [3] Cell sampling - Laser capture microdissection: Molecular analysis of tissue
    Bonner, RF
    EmmertBuck, M
    Cole, K
    Pohida, T
    Chuaqui, R
    Goldstein, S
    Liotta, LA
    [J]. SCIENCE, 1997, 278 (5342) : 1481 - &
  • [4] P53 MUTATIONS IN CERVICAL CARCINOGENESIS LOW-FREQUENCY AND LACK OF CORRELATION WITH HUMAN PAPILLOMAVIRUS STATUS
    BUSBYEARLE, RMC
    STEEL, CM
    WILLIAMS, ARW
    COHEN, B
    BIRD, CC
    [J]. BRITISH JOURNAL OF CANCER, 1994, 69 (04) : 732 - 737
  • [5] BUSCEMA J, 1988, OBSTET GYNECOL, V71, P601
  • [6] CAIRNS P, 1994, CANCER RES, V54, P1422
  • [7] REGIONAL CHROMOSOME LOCALIZATION OF HUMAN PAPILLOMAVIRUS INTEGRATION SITES NEAR FRAGILE SITES, ONCOGENES, AND CANCER CHROMOSOME BREAKPOINTS
    CANNIZZARO, LA
    DURST, M
    MENDEZ, MJ
    HECHT, BK
    HECHT, F
    [J]. CANCER GENETICS AND CYTOGENETICS, 1988, 33 (01) : 93 - 98
  • [8] TRANSITIONAL-CELL CARCINOMA OF THE BLADDER - FAILURE TO DEMONSTRATE HUMAN PAPILLOMAVIRUS DEOXYRIBONUCLEIC-ACID BY IN-SITU HYBRIDIZATION AND POLYMERASE CHAIN-REACTION
    CHANG, FJ
    LIPPONEN, P
    TERVAHAUTA, A
    SYRJANEN, S
    SYRJANEN, K
    [J]. JOURNAL OF UROLOGY, 1994, 152 (05) : 1429 - 1433
  • [9] Chu TY, 1998, INT J CANCER, V75, P199, DOI 10.1002/(SICI)1097-0215(19980119)75:2<199::AID-IJC6>3.0.CO
  • [10] 2-P